Clinical Trial Update: Glucocorticoid Treatment for Social Phobia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating glucocorticoid treatment for social anxiety disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Glucocorticoid (glucocorticoid)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Phobic Disorders, Phobias | Phase 2 | Status: TERMINATED